Inhibition of the 3′→ 5′ Exonuclease of Human DNA Polymerase ε by Fludarabine-terminated DNA

This publication has 32 references indexed in Scilit:

• Fludarabine- and gemcitabine-induced apoptosis: incorporation of analogs into DNA is a critical event
  Cancer Chemotherapy and Pharmacology, 1995
• Long-term follow-up of patients with chronic lymphocytic leukemia treated with fludarabine as a single agent
  Blood, 1993
• Induction of apoptotic cell death in chronic lymphocytic leukemia by 2- chloro-2'-deoxyadenosine and 9-beta-D-arabinosyl-2-fluoroadenine
  Blood, 1993
• Phase II trial of fludarabine phosphate in lymphoma: an effective new agent in low-grade lymphoma.
  Journal of Clinical Oncology, 1992
• Activity of fludarabine in previously treated non-Hodgkin's low-grade lymphoma: results of an Eastern Cooperative Oncology Group study.
  Journal of Clinical Oncology, 1992
• Properties of DNA polymerases δ and ϵ, and their roles in eukaryotic DNA replication
  Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1991
• Revised nomenclature for eukaryotic DNA polymerases
  European Journal of Biochemistry, 1990
• Gene deletion, a mechanism of induced mutation by arabinosyl nucleosides
  Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1989
• Incorporation of 9-β-d-arabinofuranosyl-2-fluoroadenine into HL-60 cellular RNA and DNA
  Biochemical Pharmacology, 1986
• Biologic activity of 9-β-d-arabinofuranosyl-2-fluoroadenine, a metabolically stable analog of 9-β-d-arabinofuranosyladenine
  Biochemical Pharmacology, 1977